Florina-Maria Andrica

Mrs. Florina-Maria Andrica


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2014 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SDS. Dragan
S. Dragan
FAFlorina-Maria Andrica
Florina-Maria Andrica
MSMaria-Corina Serban
Maria-Corina Serban
RTR. Timar
R. Timar
Currently, experimental and clinical evidences showed that polyphenols-rich natural products, like nutraceuticals and food supplements, may offer unique treatment modalities in type 2 diabetes mellitus (DM), due to their biological properties. Natural products modulate the carbohydrate metabolism by various mechanisms, such as restoring beta-cells integrity and physiology, enhancing insulin releasing activity, and the glucose using. Sea buckthorn berries, red grapes, bilberries, chokeberries and popular drinks like cocoa, coffee and green tea are all rich in polyphenols and may decrease the insulin response, offerin g a natural alternative of treatment in diabetes. Therefore, researches are now focused on potential efficacies of different types of polyphenols, including flavonoids, phenolic acids, lignans, anthocyans and stilbenes. Animal and human studies showed that polyphenols modulate carbohydrate and lipid metabolism, decrease glycemia and insulin resistance, increase lipid metabolism and optimize oxidative stress and inflammatory processes. It is important to understand the proper dose and duration of supplementation with polyphenols-rich extracts in order to guide effective therapeutic interventions in diabetic patients.

1 January 2016 in Archives of Medical Science
Verified
Journal Article
Open access
MVMihaela Valcovici
Mihaela Valcovici
FAFlorina-Maria Andrica
Florina-Maria Andrica
CSCorina Serban
Corina Serban
SDSimona Dragan
Simona Dragan
Anthracyclines, especially doxorubicin and daunorubicin, are the drugs of first choice in the treatment of patients with hematologic malignancies, soft-tissue sarcomas, and solid tumors. Unfortunately, the use of anthracyclines is limited by their dose-dependent and cumulative cardiotoxicity. The...

1 January 2019 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
DNDragos Nica
Dragos Nica
GDGeorge Andrei Draghici
George Andrei Draghici
FAFlorina-Maria Andrica
Florina-Maria Andrica
SPSofia Popescu
Sofia Popescu
DCDorina Coricovac
Dorina Coricovac
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis